about
Bacteriophages and their implications on future biotechnology: a reviewBacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusBacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infectionAntibiotic alternatives: the substitution of antibiotics in animal husbandry?Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administrationEfficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.Phage nanofibers induce vascularized osteogenesis in 3D printed bone scaffolds.Toward cocaine esterase therapeuticsRecombinant expression and purification of T4 phage Hoc, Soc, gp23, gp24 proteins in native conformations with stability studies.Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model.Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture.European regulatory conundrum of phage therapy.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad modelBacteriophages and medical oncology: targeted gene therapy of cancer.Ecological basis for rational phage therapy.Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood.Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.Novel approaches to developing new antibiotics for bacterial infections.Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.Chlamydia bacteriophages.Marine bacteria: potential sources for compounds to overcome antibiotic resistance.A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.Bacteriophage lambda display systems: developments and applications.Bacteriophages as vehicles for gene delivery into mammalian cells: prospects and problems.Phage therapy: eco-physiological pharmacology.A bacteriophages journey through the human body.Biofilm control with natural and genetically-modified phages.A first step toward liposome-mediated intracellular bacteriophage therapy.Delivering phage therapy per os: benefits and barriers.Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.Phages targeting infected tissues: novel approach to phage therapy.Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment.Phage Therapy: Considerations and Challenges for Development.Complete Genome Sequence of Pseudomonas aeruginosa Phage AAT-1.Bacteriophages as potential new mammalian pathogens.Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia.Observation of inflammatory responses in mice orally fed with bacteriophage T7.Prevalence and impact of bacteriophages on the presence of Escherichia coli O157:H7 in feedlot cattle and their environment.
P2860
Q21245088-A0AB9258-B2AC-454D-B6AF-35CB785A2DEFQ26799417-5704A717-FD66-424F-B337-6A0330F0C93BQ26822719-09ADF637-6DBD-4522-AD8B-CF626BAA7C29Q27027984-DE8DFDCF-1A24-4EAD-B5BC-260257139432Q28484466-0AA0331E-4D56-4005-B043-6162206367CFQ33622945-0AA90C86-0752-48AE-BA55-8DDA61F49DA1Q34005796-F34D5DB2-CA5E-4B7E-A887-0F766863B894Q34316392-45D9B0BA-4881-4EB5-A432-B71C21D5C127Q34341509-86C36627-75E3-43BC-97DB-E0F635B0524BQ34531928-F8B2929D-9E0C-481A-8D74-B1369F349DFFQ34595583-30350344-064D-4C3E-B93B-E84EFED91FD7Q34700022-FF9AA651-3DD1-4500-B13C-6D69C8CBD295Q34702499-69665504-C07E-4479-8DAB-2978A52D566CQ35204972-0A685041-89FC-4068-8B7B-56433284BD5AQ35944299-ADBE1FC0-CE13-4EAC-880F-0EA44F34ED04Q36076282-C898345A-6270-4DDC-9724-01FFD7513502Q36341673-4751A167-6AAF-4DBF-A83C-0879585955C1Q36358643-F5E44A2C-48E5-4AED-BF15-0DC3667B051AQ36593833-90797727-9EFC-4104-8DAA-BE38F5E7A174Q36676044-843D47F8-0B1C-4D99-A57C-8EBA1E2880BDQ37716726-9B1451D0-DEEF-42B6-B629-1D572D87AA4DQ37846137-75699542-0113-4DC5-8DCF-4410CBC1C477Q38103788-A4755187-8223-4285-9A85-1C35391D0085Q38131268-DB958424-3D01-497C-BDDB-B3A705F43610Q38179995-663F8EA5-90B7-4875-9FD2-5B3B1AC52087Q38222489-07957D21-E5AB-4613-B8D1-0B03652B0C8EQ38230407-4FF814C8-E4D6-45FE-AA95-854E5BA24434Q38556802-EA60AE5D-7DF5-4996-BF03-C65AE65ED211Q38756810-394D3E71-A281-496A-BC07-792E548C93BEQ38879534-A496636A-0375-4763-B60E-C7769908FDA4Q39019401-434B47E1-54D4-4AA7-95DB-79ED5CE956C4Q39023156-815B34FF-557B-4398-A5DE-C5AB035298AEQ39037957-82269A73-1118-4C0A-AAA1-457FADC3FE0AQ39139965-21BAE1BD-07E7-434F-8460-1770FB00A985Q39193510-D429F114-04B9-4969-941E-5B4E065E9AAAQ40953309-B8402CBE-9C76-4949-8B54-6CA357F1363DQ41203961-DFF3FC48-4103-4A17-A038-06264A5244E6Q41531194-07375704-6E25-4E83-B0B8-24C29A5B8756Q42213232-225B34BC-DEA6-4B9D-ADC6-0DD64720FB77Q43173627-5A2739EF-DC7C-4DD7-8744-ABA9188D714D
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bacteriophage penetration in vertebrates.
@ast
Bacteriophage penetration in vertebrates.
@en
type
label
Bacteriophage penetration in vertebrates.
@ast
Bacteriophage penetration in vertebrates.
@en
prefLabel
Bacteriophage penetration in vertebrates.
@ast
Bacteriophage penetration in vertebrates.
@en
P2093
P2860
P1476
Bacteriophage penetration in vertebrates.
@en
P2093
Dabrowska K
Switała-Jelen K
Weber-Dabrowska B
P2860
P356
10.1111/J.1365-2672.2004.02422.X
P577
2005-01-01T00:00:00Z